Table 1 A comparison of clinicopathological features between without SLNB and with SLNB groups
Patients without SLNB (n=25) | Patients with SLNB (n=35) | P value | |
|---|---|---|---|
Age (years) | 57.2±11.3 | 61.5±12.1 | NS |
BMI | 23.2±4.2 | 23.5±5.4 | NS |
T | 0.09 | ||
0 | 2 (8) | 0 (0) | |
1 | 6 (24) | 17 (48.5) | |
2 | 14 (56) | 17 (48.5) | |
3 | 2 (8) | 0 (0) | |
4 | 1 (4) | 1 (3) | |
N | <0.001 | ||
0 | 0 | 35 (100) | |
1 | 20 (80) | 0 (0) | |
2 | 2 (8) | 0 (0) | |
3 | 3 (12) | 0 (0) | |
Clinical stage | <0.001 | ||
I | 0 | 16 (46) | |
IIA | 8 (32) | 18 (51) | |
IIB | 11 (44) | 0 | |
IIIA | 2 (8) | 0 | |
IIIB | 1 (4) | 1 (3) | |
IIIC | 3 (12) | 0 | |
Histology | 0.33 | ||
IDC | 23 (92) | 35 (100) | |
Others | 2a (8) | 0 (0) | |
ER | 0.10 | ||
Negative | 7 (28) | 3 (9) | |
Positive | 18 (72) | 32 (91) | |
HER-2 | 0.24 | ||
Negative | 15 (60) | 26 (74) | |
Positive | 10 (30) | 9 (26) |